QOL of Multiple Myeloma Patients Receiving Maintenance Therapy

Video

This interview examines a study that looked at the health-related quality of life of multiple myeloma patients in a real-world setting who underwent maintenance therapy after autologous stem cell transplant.

In this interview, Rafat Abonour, MD, of the Indiana University Simon Cancer Center, discusses a study that examined the health-related quality of life of multiple myeloma patients who received maintenance therapy in a real-world setting.

Patients in the study (abstract 537) were part of the Connect MM registry. Patients had newly diagnosed disease, and the researchers compared those who received maintenance therapy (a majority with lenalidomide) after autologous stem cell transplant with those who did not.

Dr. Abonour presented results of the trial at the 58th Annual Meeting of the American Society of Hematology (ASH), held December 3–6 in San Diego, California.

Recent Videos
Mark Hamilton, MD, PhD, a hematology-oncology and bone marrow transplant (BMT) cell therapy fellow at Stanford University
Barry J Byrne, MD, PhD, the chief medical advisor of MDA and a physician-scientist at the University of Florida
Barry J Byrne, MD, PhD, the chief medical advisor of MDA and a physician-scientist at the University of Florida
Sarah Larson, MD, the medical director of the Immune Effector Cell Therapy Program in the Division of Hematology/Oncology at David Geffen School of Medicine at University of California, Los Angeles (UCLA)
David Porter, MD, the director of cell therapy and transplant at Penn Medicine
David Porter, MD, the director of cell therapy and transplant at Penn Medicine
Georg Schett, MD, vice president research and chair of internal medicine at the University of Erlangen – Nuremberg
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
© 2025 MJH Life Sciences

All rights reserved.